Working… Menu

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03049735
Recruitment Status : Completed
First Posted : February 10, 2017
Last Update Posted : December 8, 2020
Information provided by (Responsible Party):
Myovant Sciences GmbH

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 29, 2019
Actual Study Completion Date : August 24, 2020
Certification/Extension First Submitted : April 2, 2020